Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
-- Special Meeting to be held on September 26, 2025 --SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders tod...
Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.02) per share. The company reported $4.825 million in sales thi...
Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreementContract inked with outside U.S m...
Evofem Biosciences (OTC:EVFM) reported $845.00 thousand in sales this quarter. This is a 76.55 percent decrease over sales of $...
https://www.semafor.com/article/04/24/2025/fdas-marty-makary-no-plans-to-pull-abortion-pill-mifepristone
Evofem's Cost to Manufacture PHEXXI will Decrease by 55% - 60% --SAN DIEGO, March 26, 2025 /PRNewswire/ -- Evofem Bioscienc...
Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating ...
Companies Targeting Closing in Fourth Quarter of 2024Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), an...
